Showing 1 - 15 results of 15 for search 'Asuka Sugai', query time: 0.05s
Refine Results
-
1
Gemcitabine Cooperates with Everolimus to Inhibit the Growth of and Sensitize Malignant Meningioma Cells to Apoptosis Induced by Navitoclax, an Inhibitor of Anti-Apoptotic BCL-2 Fa... by Masahiro Yamamoto, Shuhei Suzuki, Keita Togashi, Asuka Sugai, Masashi Okada, Chifumi Kitanaka
Published 2022-03-01
Article -
2
Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xeno... by Masashi Okada, Shuhei Suzuki, Keita Togashi, Asuka Sugai, Masahiro Yamamoto, Chifumi Kitanaka
Published 2021-10-01
Article -
3
Domatinostat Targets the FOXM1–Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents by Yurika Nakagawa-Saito, Yuta Mitobe, Shuhei Suzuki, Keita Togashi, Asuka Sugai, Chifumi Kitanaka, Masashi Okada
Published 2023-06-01
Article -
4
-
5
-
6
-
7
Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells by Yuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, Keita Togashi, Asuka Sugai, Yukihiko Sonoda, Chifumi Kitanaka, Masashi Okada
Published 2023-08-01
Article -
8
Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing by Shuhei Suzuki, Masahiro Yamamoto, Tomomi Sanomachi, Keita Togashi, Asuka Sugai, Shizuka Seino, Masashi Okada, Takashi Yoshioka, Chifumi Kitanaka
Published 2020-08-01
Article -
9
Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs by Tomomi Sanomachi, Shuhei Suzuki, Keita Togashi, Asuka Sugai, Shizuka Seino, Masashi Okada, Takashi Yoshioka, Chifumi Kitanaka, Masahiro Yamamoto
Published 2019-10-01
Article -
10
Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction by Shuhei Suzuki, Masahiro Yamamoto, Tomomi Sanomachi, Keita Togashi, Asuka Sugai, Shizuka Seino, Takashi Yoshioka, Chifumi Kitanaka, Masashi Okada
Published 2019-07-01
Article -
11
Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction by Shuhei Suzuki, Masahiro Yamamoto, Tomomi Sanomachi, Keita Togashi, Asuka Sugai, Shizuka Seino, Takashi Yoshioka, Masashi Okada, Chifumi Kitanaka
Published 2021-08-01
Article -
12
-
13
-
14
The Laterally Extended Paramedian Forehead Flap for Nasal Reconstruction: The Delay Technique Revisited by Yoshihito Itani, MD, PhD, Takatoshi Yotsuyanagi, MD, PhD, Makoto Yamauchi, MD, PhD, Asuka Sugai, MD, Shinji Kato, MD, Ken Yamashita, MD, PhD, Noritaka Isogai, MD, PhD
Published 2020-06-01
Article -
15
Establishment of a Standardized Technique for Concha-type Microtia―How to Incorporate the Cartilage Frame into the Remnant Ear by Takatoshi Yotsuyanagi, MD, PhD, Ken Yamashita, MD, PhD, Makoto Yamauchi, MD, PhD, Tsugufumi Nakagawa, MD, Asuka Sugai, MD, Shinji Kato, MD, Ayako Gonda, MD, Akiyo Suzuki, MD, Masahiro Onuma, MD
Published 2019-07-01
Article